Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yenny Angela

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
Gabriele M Lehner, Vivien Schacht, Yenny Angela, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 28, 2020
Successful treatment of a metastatic melanoma with Talimogen laherparepvec (T-VEC) in a liver transplant patientGabriele M Lehner, Vivien Schacht, Yenny Angela, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 23, 2021
Dupilumab bei eosinophiler Zellulitis (Wells-Syndrom) - Fallbericht einer möglichen neuen TherapieoptionStephan Traidl, Yenny Angela, Alexander Kapp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 22, 2021
Dupilumab in eosinophilic cellulitis (Wells' syndrome) - case report of a potential new treatment optionStephan Traidl, Yenny Angela, Alexander Kapp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 26, 2026
Complete Regression of bilateral Choroidal Metastases secondary to a Cutaneous Melanoma under ImmunotherapyYenny Angela, Alena Riesmeier, Ralf Gutzmer, et al.
Melanoma Research|March 12, 2019
Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanomaNora Möhn, Kurt-Wolfram Sühs, Stefan Gingele, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2019
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastasesYenny Angela, Sebastian Haferkamp, Carsten Weishaupt, et al.
Frontiers in Immunology|December 15, 2025
A composite score of serum cytokines enables early identification of patients at high risk for irAEs under immune checkpoint inhibitionNina Flatt, Antje Walter, Corinna Kochanek, et al.
Contact Dermatitis|July 18, 2024
Epidemiology of patch tested patients with permanent tattoos-A comparative analysis of 9693 IVDK patients (2020-2022)Steffen Schubert, Eva Oppel, Andrea Bauer, et al.
Cancers|November 11, 2022
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 PatientsViola K DeTemple, Jessica C Hassel, Michael M Sachse, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
Gabriele M Lehner, Vivien Schacht, Yenny Angela, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 28, 2020
Successful treatment of a metastatic melanoma with Talimogen laherparepvec (T-VEC) in a liver transplant patientGabriele M Lehner, Vivien Schacht, Yenny Angela, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 23, 2021
Dupilumab bei eosinophiler Zellulitis (Wells-Syndrom) - Fallbericht einer möglichen neuen TherapieoptionStephan Traidl, Yenny Angela, Alexander Kapp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 22, 2021
Dupilumab in eosinophilic cellulitis (Wells' syndrome) - case report of a potential new treatment optionStephan Traidl, Yenny Angela, Alexander Kapp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 26, 2026
Complete Regression of bilateral Choroidal Metastases secondary to a Cutaneous Melanoma under ImmunotherapyYenny Angela, Alena Riesmeier, Ralf Gutzmer, et al.
Melanoma Research|March 12, 2019
Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanomaNora Möhn, Kurt-Wolfram Sühs, Stefan Gingele, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2019
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastasesYenny Angela, Sebastian Haferkamp, Carsten Weishaupt, et al.
Frontiers in Immunology|December 15, 2025
A composite score of serum cytokines enables early identification of patients at high risk for irAEs under immune checkpoint inhibitionNina Flatt, Antje Walter, Corinna Kochanek, et al.
Contact Dermatitis|July 18, 2024
Epidemiology of patch tested patients with permanent tattoos-A comparative analysis of 9693 IVDK patients (2020-2022)Steffen Schubert, Eva Oppel, Andrea Bauer, et al.
Cancers|November 11, 2022
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 PatientsViola K DeTemple, Jessica C Hassel, Michael M Sachse, et al.
Pageof 4